> Back to JHP Titles
MEDICAL AND WORK LOSS
BURDEN OF PRE-DIALYSIS CHRONIC KIDNEY DISEASE AND
RELATED ANEMIA:
AN EMPLOYER’S PERSPECTIVE
Moyneur E, MA; Bookhart BK,
MBA, MPH; Mody SH, PharmD, MBA; Fournier A, MA;
Mallet D, MBA, MHA; Duh MS, MPH, ScD
1. National Kidney Disease Education
Program. Chronic Kidney Disease in the United States.
Accessed at http://www.nkdep.nih.gov/resources/nkdep_ckd_presentation.ppt.
2. United States Renal Data System: USRDS 2005 Annual
Data Report. The National Institutes of Health, National
Institute of Diabetes and Digestive Kidney Diseases,
Bethesda, MD 2005.
3. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS.,
Prevalence of chronic kidney disease and decreased kidney
function in the adult US population: Third national health
and nutrition examination survey, Am J Kidney Dis. 2003
Jan;41(1):1-12.
4. Ershler WB et al. Economic burden of patients with
anemia in selected diseases. Value Health 2005;8(6):629-38.
5. London R, Solis A, Goldberg GA, Wade S, Chan WW.,Examination
of resource use and clinical interventions associated
with chronic kidney disease in a managed care population,J
Manag Care Pharm. 2003 May-Jun;9(3):248-55.
6. Kazmi WH, Kausz AT, Khan S, Abichandani R, Ruthazer
R, Obrador GT, Pereira BJ.,Anemia: an early complication
of chronic renal insufficiency,Am J Kidney Dis. 2001
Oct;38(4):803-12.
7. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J.,
Association of kidney function with anemia: The third
national health and nutrition examination survey (1988-1994).
Arch Intern Med 2002;162:1401-08.
8. McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber
DL, Tang KL, Tse TF, Wasserman B, Leiserowitz M., The
prevalence of anemia in patients with chronic kidney
disease. Curr Med Res Opin 2004;20:1501-10.
9. Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP,
Rudnick MR, Benz RL., Health-related quality of life
associated with recombinant human erythropoietin therapy
for predialysis chronic renal disease patients. Am J
of Kidney Dis 1995;25(4):548-54.
10. Khan SS, Kazmi WH, Abichandani R, Tighiouart H, Pereira
BJ, Kausz AT. Health care utilization among patients
with chronic kidney disease. Kidney Int. 2002 Jul;62(1):229-36.
11. Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos
KC.,Treating anemia early in renal failure patients slows
the decline of renal function: a randomized controlled
trial.,Kidney Int. 2005 Feb;67(2):779; author reply 779-80.
12. Kausz A.T., Steinberg E.P., Nissenson A.R., Pereira
B.J.G., Prevalence and management of anemia among patients
with chronic kidney disease in a health maintenance organization.
Dis Manag Health Outcomes 2002;10:505-13.
13. Obrador GT and Pereira BJG. Anaemia of chronic kidney
disease: an underrecognized and under-treated problem.
Nephrol Dial Transplant 2002;17[Suppl 11]:44-6.
14. London R, Solis A, Goldberg GA, Wade S, Ryu S.,Health
care resource utilization and the impact of anemia management
in patients with chronic kidney disease.,Am J Kidney
Dis. 2002 Sep;40(3):539-48.
15. Nissenson AR, Wade S, Goodnough T, Knight K, Dubois
RW.,Economic burden of anemia in an insured population.,J
Manag Care Pharm. 2005 Sep;11(7):565-74.
16. Romano PS, Roos LL, Jollis JG. Adapting a clinical
comorbidity index for use with ICD-9-CM administrative
data: differing perspectives. J Clin Epidemiol. 1993
Oct;46(10):1075-9; discussion 1081-90.
17. Section III. Treatment of renal anemia. Nephrol Dial
Transplant 2004;19[Suppl 2]:ii16-31.
18. Mody SH, Boyce SP, Moyneur E, Piech CT, Economic
impact of untreated anemia in non-dialysis chronic kidney
disease (NDCKD) patients. J Am Soc Nephrol 2003;14[Suppl]:457A.
19. Collins AJ. Anemia management prior to dialysis:
cardiovascular and cost-benefit observations. Nephrol
Dial Transplant 2003;18[Suppl 2]:ii2-6. |
